Authors: Proost, P Schutyser, E Menten, P Struyf, S Wuyts, A Opdenakker, G Detheux, M Parmentier, M Durinx, C Lambeir, AM Neyts, J Liekens, S Maudgal, PC Billiau, A Van Damme, J

Citation: P. Proost et al., Amino-terminal truncation of CXCR3 agonists impairs receptor signaling andlymphocyte chemotaxis, while preserving antiangiogenic properties, BLOOD, 98(13), 2001, pp. 3554-3561

Authors: Struyf, S Stoops, G Van Coillie, E Gouwy, M Schutyser, E Lenaerts, JP Fiten, P Van Aelst, I Proost, P Opdenakker, G Van Damme, J

Citation: S. Struyf et al., Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants, BIOCHEM, 40(39), 2001, pp. 11715-11722

Authors: Schutyser, E Struyf, S Menten, P Lenaerts, JP Conings, R Put, W Wuyts, A Proost, P Van Damme, J

Citation: E. Schutyser et al., Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells, J IMMUNOL, 165(8), 2000, pp. 4470-4477

Authors: Proost, P Menten, P Struyf, S Schutyser, E De Meester, I Van Damme, J

Citation: P. Proost et al., Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78 beta into a most efficient monocyte attractant and CCR1 agonist, BLOOD, 96(5), 2000, pp. 1674-1680

Authors: Wuyts, A Schutyser, E Menten, P Struyf, S D'Haese, A Bult, H Opdenakker, G Proost, P Van Damme, J

Citation: A. Wuyts et al., Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC chemokine from alveolar macrophages, BIOCHEM, 39(47), 2000, pp. 14549-14557

Authors: Menten, P Struyf, S Schutyser, E Wuyts, A De Clercq, E Schols, D Proost, P Van Damme, J

Citation: P. Menten et al., The LD78 beta isoform of MIP-1 alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine, J CLIN INV, 104(4), 1999, pp. R1-R5